Who owns Medline (MDLN)? Superinvestor holders
6 superinvestors of the 157 tracked here hold Medline (MDLN) in their latest 13F filing, with $2B between them. Stephen Mandel gives it the most weight: 5.06% of the reported portfolio. In their latest reported quarter, Stephen Mandel added; John Armitage, Henry Ellenbogen, Andreas Halvorsen and George Soros and 1 more reduced.
Steve Cohen, Lee Ainslie, Rob Citrone and Eric Bannasch sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 6 of 157
- Biggest holder
- Stephen Mandel, $827M
- Largest weight
- Stephen Mandel, 5.06%of their portfolio
- Combined value
- $2B
- Bought last quarter
- 1
- Sold last quarter
- 9
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Stephen MandelLone Pine Capital | 5.06% | $827M | 20.97M | ▲ Added 78% | +9.18M | Q2 2026 |
| 2 | John ArmitageEgerton Capital | 4.69% | $460.9M | 13.28M | ▼ Reduced 19% | −3.19M | Q3 2026 |
| 3 | Henry EllenbogenDurable Capital Partners | 1.01% | $103.6M | 2.63M | ▼ Reduced 64% | −4.64M | Q2 2026 |
| 4 | Andreas HalvorsenViking Global Investors | 0.54% | $190.9M | 4.84M | ▼ Reduced 58% | −6.59M | Q2 2026 |
| 5 | George SorosSoros Fund Management | 0.54% | $34.8M | 1M | ▼ Reduced 39% | −634.78K | Q3 2026 |
| 6 | Baillie Gifford teamBaillie Gifford & Co | 0.37% | $389.9M | 11.24M | ▼ Reduced 0.9% | −106.62K | Q3 2026 |
Sold out last quarter
- Steve Cohenwas $147M · Q2 2026
- Lee Ainsliewas $35.4M · Q2 2026
- Rob Citronewas $11.1M · Q2 2026
- Eric Bannaschwas $3.9M · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 3 | 25.52M | $885.6M | 0 | 4 |
| Q2 2026 | 157 | 7 | 57.99M | $2.3B | 5 | 6 |
| Q1 2026 | 157 | 9 | 50.47M | $2.2B | 6 | 8 |
| Q4 2025 | 157 | 11 | 45.87M | $1.9B | 11 | 0 |
| Q3 2025 | 157 | 0 | — | — | 0 | 0 |
| Q2 2025 | 157 | 0 | — | — | 0 | 0 |
| Q1 2025 | 156 | 0 | — | — | 0 | 0 |
| Q4 2024 | 156 | 0 | — | — | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| John Armitage | 13.28M | 16.47M | 4.37M | — | — | — | — | — |
| Baillie Gifford team | 11.24M | 11.34M | 9.98M | 10.41M | — | — | — | — |
| George Soros | 1M | 1.64M | 1.29M | 1.58M | — | — | — | — |
| Stephen Mandel | · | 20.97M | 11.79M | 11.72M | — | — | — | — |
| Andreas Halvorsen | · | 4.84M | 11.43M | 6.96M | — | — | — | — |
| Henry Ellenbogen | · | 2.63M | 7.27M | 6.9M | — | — | — | — |
| Eric Bannasch | — | 100K | — | — | — | — | — | — |
| Steve Cohen | · | — | 3.3M | — | — | — | — | — |
| Lee Ainslie | · | — | 796.08K | 796.08K | — | — | — | — |
| Rob Citrone | · | — | 250K | — | — | — | — | — |
| Ken Griffin | · | — | — | 6.01M | — | — | — | — |
| Marc Stad | — | — | — | 525K | — | — | — | — |
| Daniel Sundheim | — | — | — | 377.13K | — | — | — | — |
| Peter Kolchinsky | · | — | — | 335K | — | — | — | — |
| Andrew Spokes | — | — | — | 260K | — | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own MDLN?
In their latest 13F filings: Stephen Mandel (5.06% of the portfolio, $827M), John Armitage (4.69% of the portfolio, $460.9M), Henry Ellenbogen (1.01% of the portfolio, $103.6M), Andreas Halvorsen (0.54% of the portfolio, $190.9M), George Soros (0.54% of the portfolio, $34.8M), Baillie Gifford team (0.37% of the portfolio, $389.9M).
Who bought MDLN last quarter?
Stephen Mandel (added 78%). “Last quarter” is each investor's latest reported quarter.
Who sold MDLN last quarter?
Reduced: John Armitage (19% fewer shares), Henry Ellenbogen (64% fewer shares), Andreas Halvorsen (58% fewer shares), George Soros (39% fewer shares), Baillie Gifford team (0.9% fewer shares). Sold out entirely: Steve Cohen (was $147M), Lee Ainslie (was $35.4M), Rob Citrone (was $11.1M), Eric Bannasch (was $3.9M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Medline (MDLN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/MDLN/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to MDLN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.